about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersA novel zinc finger gene is fused to EWS in small round cell tumorThe human archain gene, ARCN1, has highly conserved homologs in rice and DrosophilaAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesGenome-wide association studies identify four ER negative-specific breast cancer risk lociCommon breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersIs Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshopGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskChromosomal localizations and molecular analysis of TDG gene-related sequencesLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairInvolvement of MBD4 inactivation in mismatch repair-deficient tumorigenesisPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSComparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testingLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Evaluation of a 5-tier scheme proposed for classification of sequence variants using bioinformatic and splicing assay data: inter-reviewer variability and promotion of minimum reporting guidelines.Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) methodMale breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.WT1 gene analysis in sporadic early-onset and bilateral wilms tumor patients without associated abnormalities.Wilms tumor in monozygous twins: clinical, pathological, cytogenetic and molecular case report.Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instabilityEvaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersCOGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.Prediction and assessment of splicing alterations: implications for clinical testing.Common genetic variants and modification of penetrance of BRCA2-associated breast cancerSingle-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.Exploring the link between MORF4L1 and risk of breast cancer.Familial adenomatous polyposis-associated desmoids display significantly more genetic changes than sporadic desmoids.Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriersDetermination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.Breast-cancer risk in families with mutations in PALB2
P50
Q21144874-7DE137FD-780C-44E8-8E8F-52F8BB7B1A7EQ24290116-530A2166-1E1D-4091-9F62-43E3ADE5EA3EQ24322079-A7B5BD6E-5E2C-4330-BA24-204F1F6443B8Q24531993-292B2C2A-B001-4843-9A00-2AE9D67378B6Q24622610-71202DD0-7A00-430A-A00F-4662DA38554DQ24655824-595A69AA-CBC0-4D8B-A7E2-417A72242222Q26829595-056294E0-D48C-427C-A6A9-BAC226890DFEQ27008356-3D36DEA4-C1F1-4A96-AA21-C635A8D32D8EQ28249078-0BB1A21D-55F8-40DB-B22A-18566ADBC5C4Q28267893-077CB8C2-2556-49AA-80BE-FBAEFCECF2E2Q28269118-06F34EDA-094A-47BC-94AE-246213873885Q28584533-9893BB55-0CC2-484B-865A-CAEC2A1E2D7BQ28652730-F19A5C23-EDEC-4CE3-8F8F-CFE19E1E8221Q29416989-2379328E-E6F7-4457-9B27-0A672BDE9037Q30250038-669DDA40-8BC2-49BA-9A01-CF77F79B6BA1Q30252854-09875166-0FE9-4F20-A4A8-DEFE9210F653Q30374367-1448006D-9FDE-4C1C-BF95-3F3718A80079Q30657823-1D177756-0F55-4BF3-8EF4-CB57988E81E0Q30717784-1198A8B6-3157-4986-9B53-B5D8202F234DQ31043651-2D877318-BADF-4011-A942-2F6E75A726BFQ31049299-9BE19A9A-5B2F-420F-A04A-77C5C18EEE51Q31082788-9B1C79CE-EA2B-457B-8835-6D5AFD731C10Q33207533-44447828-7169-4E50-BBCA-503344E56367Q33214171-8AF25AB5-C6C7-40DF-833D-FEA72AB4565FQ33224957-E7B54BBD-FD4B-4EFC-88F9-4D40DC53C2D0Q33327077-7221F1DB-BC71-429E-818D-7AA6900785EBQ33522197-21E5091E-D3CD-4F23-8513-BE777FF96967Q33614244-BB2D8761-D560-49A1-B339-07ECE9631C26Q33630773-10DE1E48-3FB6-4DF8-AED9-F28DC1CA6299Q33704900-BA12B968-232C-4E94-8097-1E9188528E00Q33742096-A6ADC4FD-1DB8-4507-AC90-6A22E25AB2ABQ33782791-9DBB324B-1E5C-41E6-87AE-BB5E30DC46AFQ33863235-6883A206-02C3-4421-86ED-1EA41B1F25A1Q34023407-AEB8189A-C06F-4EC0-AC4B-204B43280A6BQ34081324-08A77751-759F-4098-ABB7-710673C1560CQ34084450-491F8572-63D4-4939-8A80-6BAAD4B3EC48Q34115636-00AD01BF-4196-4457-A428-162242E5D7CFQ34116553-F3A4E863-9239-41F5-86FA-867FE9B8F943Q34120135-4BDE9D8E-6F7E-4223-B538-70EFE0F5D182Q34148873-5443FF3A-45F4-45FC-B0F4-2B8F17A8FC1B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paolo Radice
@ast
Paolo Radice
@en
Paolo Radice
@es
Paolo Radice
@nl
Paolo Radice
@pt
Paolo Radice
@sl
type
label
Paolo Radice
@ast
Paolo Radice
@en
Paolo Radice
@es
Paolo Radice
@nl
Paolo Radice
@pt
Paolo Radice
@sl
altLabel
Radice P
@en
prefLabel
Paolo Radice
@ast
Paolo Radice
@en
Paolo Radice
@es
Paolo Radice
@nl
Paolo Radice
@pt
Paolo Radice
@sl
P1053
O-3119-2013
P106
P1153
7005103817
P21
P31
P3829
P496
0000-0001-6298-4111